Drug
Uridine Triphosphate clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2000
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
2 studies that test it; most in 2000 (1)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Memorial Sloan Kettering Cancer Center (1) · Merck Sharp & Dohme LLC (1) · Jonsson Comprehensive Cancer Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Uridine Triphosphate is read from its arms, and is right about nine times in ten.
Testing it · 3
- Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)TerminatedPhase 2Merck Sharp & Dohme LLCNCT01381666Written as INS316 solution for inhalation
- INS316 Compared With Saline for Sputum Collection in Diagnosing Lung CancerStatus unknownNot applicableJonsson Comprehensive Cancer CenterNCT00033527Written as INS316
- INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung CancerCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00008255Written as INS316
Given in every arm · 1 — Uridine Triphosphate is usual care beside what is tested
Codes
What other systems call Uridine Triphosphate · ClinicalTrials.gg INT008387
- MeSH (NLM) D014544Uridine TriphosphateOne source NLM
- UNII (FDA) UT0S826Z60URIDINE 5'-TRIPHOSPHATEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014544 | Uridine Triphosphate | One source NLM |
| UNII (FDA) | UT0S826Z60 | URIDINE 5'-TRIPHOSPHATE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.